Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 28 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT05511909
- Conditions
- Anxiety, Anxiety Disorders, Chemically-Induced Disorders, +7 more
- Locations
-
- Kahlert Institute for Addictino Medicin Baltimore, Maryland, United States
Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
NCT05555485
- Conditions
- Agnosia, Analgesia, Nervous System Diseases, +6 more
- Locations
-
- University of Texas Medical Branch Galveston, Texas, United States
NCT06487533
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
- Locations
-
- Hazelden Betty Ford Foundation Center City, Minnesota, United States
- Battelle Memorial Institute Columbus, Ohio, United States
NCT07079826
- Conditions
- Anxiety Disorders, Behavior, Behavioral Symptoms, +8 more
- Locations
-
- UPMC Presbyterian Pittsburgh, Pennsylvania, United States
CEDRN: Opioid Registry
NCT07466784
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +7 more
- Locations
-
- Vancouver General Hospital Vancouver, British Columbia, Canada
NCT06442566
- Conditions
- Chronic Pain, Neurologic Manifestations, Opioid Withdrawal, +3 more
- Locations
-
- Medical University of South Carolina Charleston, South Carolina, United States
NCT05027919
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- University of Maryland Baltimore, Maryland, United States
NCT04325659
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +6 more
- Locations
-
- Behavioral Pharmacology Research Unit Baltimore, Maryland, United States
NCT04470050
- Conditions
- Aberrant Motor Behavior in Dementia, Behavior, Behavioral Symptoms, +15 more
- Locations
-
- BioXcel Clinical Research Site Miami Lakes, Florida, United States
- BioXcel Clinical Research Site Marlton, New Jersey, United States
- BioXcel Clinical Research Site New York, United States
NCT03485430
- Conditions
- Analgesics, Opioid, Chemically-Induced Disorders, Chronic Pain, +9 more
- Locations
-
- Lund University Hospital Lund, Skåne County, Sweden
- Paincentre Sahlgrenska University Hospital Gothenburg, Västra Götaland County, Sweden
- Pain and rehabilitation centre Linköping University Hospital Linköping, Östergötland County, Sweden
NCT05053503
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- Hazelden Betty Ford Foundation Rancho Mirage, California, United States
- Gaudenzia, Inc. Crownsville, Maryland, United States
- Hazelden Betty Ford Foundation Center City, Minnesota, United States
- Hazelden Betty Ford Foundation Plymouth, Minnesota, United States
NCT04218240
- Conditions
- Opioid Withdrawal
- Locations
-
- Mountain Manor Treatment Center Baltimore, Maryland, United States
- John Mariani New York, United States
- Treatment Research Center Philadelphia, Pennsylvania, United States
NCT04049799
- Conditions
- Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +8 more
- Locations
-
- Mountain Area Health Education Center Asheville, North Carolina, United States
- UNC Chapel Hill Horizons Chapel Hill, North Carolina, United States
- University of Vermont Burlington, Vermont, United States
- Virginia Commonwealth University Richmond, Virginia, United States
Oral Cannabidiol for Opioid Withdrawal
NCT04238754
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Opioid Tapering After Spine Surgery
NCT04140955
- Conditions
- Behavior, Chemically-Induced Disorders, Health Behavior, +14 more
- Locations
-
- Aarhus University Hospital Aarhus, Central Jutland, Denmark
NCT03789214
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +8 more
- Locations
-
- Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States
Open-Label, Safety Study of Lofexidine
NCT02363998
- Conditions
- Opioid Withdrawal
- Locations
-
- Little Rock, Arkansas, United States
- Springdale, Arkansas, United States
- San Diego, California, United States
- Fort Lauderdale, Florida, United States
NCT04126083
- Conditions
- Opioid Withdrawal
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal
NCT04731935
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- Recovery Unplugged Austin, Texas, United States
NCT04075214
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- Recovery Unplugged Austin, Texas, United States